FDA Sets Deadline for Decision on Plan B Pill
The Food and Drug Administration is to decide by Sept. 1 whether a morning-after contraceptive pill can be sold without a doctor’s prescription.
The long-awaited deadline was disclosed in a letter sent to senators by Health and Human Services Secretary Mike Leavitt.
The news prompted two Democratic senators, Patty Murray of Washington and Hillary Rodham Clinton of New York, to announce that they would allow a vote on the confirmation of Lester Crawford as FDA commissioner.
The two senators had placed a hold on the nomination because of the lack of a decision on the pill, known as Plan B.
Crawford has been acting or deputy commissioner for three years.
Start your day right
Sign up for Essential California for news, features and recommendations from the L.A. Times and beyond in your inbox six days a week.
You may occasionally receive promotional content from the Los Angeles Times.
